0000950170-23-070416.txt : 20231214 0000950170-23-070416.hdr.sgml : 20231214 20231214163008 ACCESSION NUMBER: 0000950170-23-070416 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231212 FILED AS OF DATE: 20231214 DATE AS OF CHANGE: 20231214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Waltermire Robert E. CENTRAL INDEX KEY: 0001876996 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33277 FILM NUMBER: 231487422 MAIL ADDRESS: STREET 1: FOUR TOWER BRIDGE, 200 BARR HARBOR DRIVE STREET 2: SUITE 200 CITY: WEST CONSHOHOCKEN STATE: PA ZIP: 19428 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MADRIGAL PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001157601 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 BARR HARBOR DRIVE, SUITE 400 CITY: WEST CONSHOHOCKEN STATE: PA ZIP: 19428 BUSINESS PHONE: 404-380-9263 MAIL ADDRESS: STREET 1: 200 BARR HARBOR DRIVE, SUITE 400 CITY: WEST CONSHOHOCKEN STATE: PA ZIP: 19428 FORMER COMPANY: FORMER CONFORMED NAME: SYNTA PHARMACEUTICALS CORP DATE OF NAME CHANGE: 20010815 4 1 ownership.xml 4 X0508 4 2023-12-12 0001157601 MADRIGAL PHARMACEUTICALS, INC. MDGL 0001876996 Waltermire Robert E. C/O MADRIGAL PHARMACEUTICALS, INC. 200 BARR HARBOR DRIVE, SUITE 200 WEST CONSHOHOCKEN PA 19428 false true false false Senior VP, Chief Pharma Dev. false Common Stock 2023-12-12 4 M false 1300 87.92 A 6967 D Common Stock 2023-12-12 4 S false 500 216.00 D 6467 D Common Stock 2023-12-12 4 S false 800 219.00 D 5667 D Common Stock 2023-12-13 4 M false 2500 87.92 A 8167 D Common Stock 2023-12-13 4 S false 1500 225.00 D 6667 D Common Stock 2023-12-13 4 S false 1000 226.00 D 5667 D Stock Option (Right to Buy) 87.92 2023-12-12 4 M false 1300 0 D 2031-08-02 Common Stock 1300 23700 D Stock Option (Right to Buy) 87.92 2023-12-13 4 M false 2500 0 D 2031-08-02 Common Stock 2500 21200 D All shares issued pursuant to the exercise of the options reported herein represent 3,800 shares underlying an overall option award of 35,000 shares. All exercised options had vested. As to the overall option for 35,000 shares, 25% of the shares underlying the option vested on August 2, 2022 and, thereafter, 6.25% of the shares vested, or will vest, on the last day of each successive three-month period, provided the Reporting Person continues in service with the Issuer on each such date. *As attorney-in-fact for Reporting Person /s/ Brian J. Lynch* 2023-12-14